Sintx Technologies (SINT) Net Income towards Common Stockholders (2013 - 2026)
Sintx Technologies (SINT) posted quarterly Net Income towards Common Stockholders of -$2.8 million for Q1 2026, down 22.87% year-over-year from -$3.7 million in Q1 2025, and down 27.36% quarter-over-quarter from -$2.2 million in Q4 2025.
Sintx Technologies (SINT) Net Income towards Common Stockholders (2013 - 2026) Analysis & Trends
Sintx Technologies' Net Income towards Common Stockholders history runs 14 years deep, the most recent figure standing at -$2.8 million for Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders fell 22.87% year-over-year to -$2.8 million; the TTM figure through Mar 2026 stood at -$17.6 million (down 41.64% YoY), while the FY2025 annual figure was -$17.1 million, down 54.96% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$2.8 million, down from -$2.2 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was -$1.7 million in Q4 2024, with the low at -$10.3 million in Q3 2025.
- The 5-year median for Net Income towards Common Stockholders is -$2.7 million (2022), against an average of -$3.7 million.
- The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders tumbled 294.0% in 2022, then soared 72.4% in 2023.
- Sintx Technologies' Net Income towards Common Stockholders stood at -$8.4 million in 2022, then jumped by 72.4% to -$2.3 million in 2023, then grew by 26.97% to -$1.7 million in 2024, then tumbled by 30.68% to -$2.2 million in 2025, then retreated by 27.36% to -$2.8 million in 2026.
- Business Quant data shows SINT's Net Income towards Common Stockholders at -$2.8 million in Q1 2026, -$2.2 million in Q4 2025, and -$10.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Sintx Technologies | 7.53 Mn | 7.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.82 Mn |
| Dec 31, 2025 | -2.22 Mn |
| Sep 30, 2025 | -10.26 Mn |
| Jun 30, 2025 | -2.32 Mn |
| Mar 31, 2025 | -2.30 Mn |
| Dec 31, 2024 | -1.70 Mn |
| Sep 30, 2024 | -6.24 Mn |
| Jun 30, 2024 | -2.20 Mn |
| Mar 31, 2024 | -3.73 Mn |
| Dec 31, 2023 | -2.32 Mn |
| Sep 30, 2023 | -3.19 Mn |
| Jun 30, 2023 | -2.48 Mn |
| Mar 31, 2023 | -4.44 Mn |
| Dec 31, 2022 | -8.41 Mn |
| Sep 30, 2022 | -2.72 Mn |
| Jun 30, 2022 | -2.51 Mn |
| Mar 31, 2022 | -2.85 Mn |
| Dec 31, 2021 | -2.13 Mn |
| Sep 30, 2021 | -2.34 Mn |
| Jun 30, 2021 | -2.20 Mn |